Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$2.55 - $5.07 $2,805 - $5,577
-1,100 Reduced 3.41%
31,203 $129,000
Q4 2023

Feb 07, 2024

SELL
$1.67 - $2.83 $12,262 - $20,780
-7,343 Reduced 18.52%
32,303 $84,000
Q3 2023

Oct 31, 2023

BUY
$1.54 - $2.42 $2,756 - $4,331
1,790 Added 4.73%
39,646 $74,000
Q2 2023

Jul 19, 2023

BUY
$1.32 - $2.81 $49,969 - $106,375
37,856 New
37,856 $95,000

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.6B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.